Safety, tolerability and pharmacodynamics of apical sodium-dependent bile acid transporter inhibition with volixibat in healthy adults and patients with type 2 diabetes mellitus: a randomised placebo-controlled trial

Peer Review reports

Original Submission
4 Jul 2017	Submitted	Original manuscript
7 Sep 2017	Author responded	Author comments - Renger Tiessen
Resubmission - Version 2
7 Sep 2017	Submitted	Manuscript version 2
10 Dec 2017	Reviewed	Reviewer Report - Cristiane Villela-Nogueira
20 Dec 2017	Author responded	Author comments - Renger Tiessen
Resubmission - Version 3
20 Dec 2017	Submitted	Manuscript version 3
Publishing
22 Dec 2017	Editorially accepted
5 Jan 2018	Article published	10.1186/s12876-017-0736-0

Back to article page